Ironwood Pharmaceuticals Inc expected to post earnings of 35  cents a share - Earnings Preview

Ironwood Pharmaceuticals

15/02/2022 14:02

* Ironwood Pharmaceuticals Inc  IRWD.OQ   IRWD.O  is
expected
to show a fall in quarterly revenue when it reports  results on
February 17. 
    * The Boston Massachusetts-based  company is expected to
report  a
5.8% decrease in revenue to $109.875 million from $116.68
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Ironwood
Pharmaceuticals
Inc is for earnings of 35 cents per share. For the same quarter
last year, the company reported earnings of 36 cents per share.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Ironwood
Pharmaceuticals Inc is $13​, about 17.9% above​ its last closing
price of $10.67. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  0.31        0.31       0.33      Beat    6.5
 Jun. 30 2021  0.23        0.23       0.34      Beat    47.8
 Mar. 31 2021  0.22        0.21       0.24      Beat    16.5​
 Dec. 31 2020  0.29        0.29       0.36      Beat    24.8
 ​​Sep.        0.15        0.15       0.23      Beat    51.3
 30 2020                                                
 Jun. 30 2020  0.09        0.09       0.16      Beat    81.8​
 Mar. 31 2020  0.04        0.05       0.04      Missed  -20
 Dec. 31 2019  0.25        0.24       0.30      Beat    26.9
 This summary was machine generated February 15 at 14:02 GMT. 
All figures in US dollars  unless otherwise stated